Search

Your search keyword '"TOMASELLO, G"' showing total 709 results

Search Constraints

Start Over You searched for: Author "TOMASELLO, G" Remove constraint Author: "TOMASELLO, G"
709 results on '"TOMASELLO, G"'

Search Results

4. Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO

6. Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options

7. Corrigendum to “Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response—the Neo-Runner study”: [ESMO Open 9 (2024) 10.1016/j.esmoop.2024.103665]

8. Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO

9. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO

10. CORRELATION BETWEEN IBD, INTESTINAL DYSBIOSIS, DIET AND MOOD TONE DISEASE: ANALYSIS OF LITERATURE

11. Biliary tract cancer: current challenges and future prospects

13. Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies

14. Dissecting the genetic heterogeneity of gastric cancer

15. New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

16. Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

18. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

20. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

21. INFLAMMATORY BOWEL DISEASE AND INFGERTILITY: ANALYSIS OF LITERATURE AND FUTURE PERSPECTIVES

23. A BRIEF GUIDE TO THE ANATOMICAL DISSECTION OF THE STOMACH

24. A rare case of perforated ileal diverticulitis in a young man: A case report and literature review

25. Amyand’s hernia, an unknown entity that may cause surgeons difficulty: Our experience and literature review

26. PD-009 Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

29. A BRIEF DISSECTION GUIDE TO HUMAN THORAX

30. CT-GUIDED TRANSTHORACIC NEEDLE BIOPSY: ADVANTEGES IN HISTOPATHOLOGICAL AND MOLECULAR TESTS

31. A DISSECTION'S GUIDE TO HUMAN ABDOMINAL CAVITY

32. ORAL MICROBIOTA: CHARACTERISTICS, RELATED PATHOLOGIES AND FUTURE PROSPECTS

33. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

34. SO-24 Circulating tumor DNA variant allelic fraction as a surrogate for disease burden estimation in patients with RAS wild-type metastatic colorectal cancer: A secondary endpoint of the VALENTINO study

37. Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient

39. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

40. A BRIEF DISSECTION'S GUIDE TO NORMAL MEDIASTINAL ANATOMY

41. RADIOPROTECTION IN 2018: AN UPDATE

43. A BRIEF ANATOMO-SURGICAL DISSECTION GUIDE TO HUMAN NECK: RESULTS OF THE COLLABORATION BETWEEN THE UNIVERSITY OF PALERMO AND THE UNIVERSITY OF MALTA

44. CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS

45. LYCOPENE AND PROSTATE CANCER: AN OVERVIEW

47. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience

49. Prognostic role of blood cell count-based immuno-inflammatory parameters in the Valentino trial

50. Treatments (tx) after progression to first-line FOLFOXIRI + bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts): A pooled analysis of TRIBE and TRIBE-2 studies by GONO

Catalog

Books, media, physical & digital resources